US Patent Number
6503922
Publication Date
1-7-2003
Abstract
Pharmaceutical compounds comprising bridged nicotine analogs of N-octylnicotinium iodide (NONI) having selective antagonist properties at α3β2-containing nicotinic receptor subtypes, and compositions containing these compounds. The compounds and compositions are used to treat central nervous system pathologies.
Assignees
University of Kentucky Research Foundation, Lexington, KY (US)
Application Number
09/941,926
Filing Date
08/30/2001
Recommended Citation
Crooks, Peter A.; Dwoskin, Linda P.; Xu, Rui; and Grinevich, Vladimir P., "Bridged Nicotine Compounds for Use in the Treatment of CNS Pathologies" (2003). Pharmaceutical Sciences Faculty Patents. 71.
https://uknowledge.uky.edu/ps_patents/71
